PureTech Health (PTCHF) to Release Quarterly Earnings on Wednesday

PureTech Health (OTCMKTS:PTCHF) is expected to issue its results before the market opens on Wednesday, April 29th. Analysts expect the company to announce earnings of ($0.1940) per share and revenue of $1.90 million for the quarter.

PureTech Health Price Performance

OTCMKTS PTCHF opened at $1.76 on Wednesday. PureTech Health has a twelve month low of $1.49 and a twelve month high of $1.90. The stock has a 50-day simple moving average of $1.63 and a 200 day simple moving average of $1.69.

About PureTech Health

PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.

The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.